Aerobic Exercise in Patients With Pulmonary Hypertension
NCT00678821
Cardiovascular Diseases, Hypertension
Bethesda, Maryland, United States
View Trial DetailsNCT Number: NCT06260930
The main aim of this study is to detect the value of transthoracic ultrasonography in the diagnosis and assessment of ILDs in correlation to chest X- ray, blood gases, pulmonary function test and echocardiography and to compare it with high resolution CT (HRCT) as a golden diagnostic investigation.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Interstitial lung disease (ILD) refers to a group of disorders that are characterized by varying combinations of inflammation and fibrosis involving the space between the epithelial and endothelial basement membranes.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 months
To estimate the sensitivity and specificity of the lung sonography for interstitial disease screening in comparison with HRCT. [Time Frame: 12 months]
Looking for future studies?
Notify MeAswan University
Other
Role od Chest Ultrasonography in Interstitial Lung Diseases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00678821
Cardiovascular Diseases, Hypertension
Bethesda, Maryland, United States
View Trial DetailsNCT05001009
Brain Diseases, Cancer
Palo Alto, California, United States
View Trial DetailsNCT06447831
COPD Chronic Obstructive Pulmonary Disease, Chronic Disease
Québec, Quebec, Canada
View Trial DetailsNCT05916404
Behavior, Interstitial Lung Disease
Ankara, Çankaya, Turkey (Türkiye)
View Trial Details